RIGL

RIGEL PHARMACEUTICALS INC

Biotechnology · Biotechnology

$55.85 sample

-0.03 (-0.05%) 1D

Market cap

$117.6B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-11

Alerts

8

Price$55.85 +5.96% 3M daily closessample

55.8852.71

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 23INSInsider sell: EVP, Operations
Sep 18INSInsider sell: Chief Executive Officer
Sep 11SECDEF 14A filed
Sep 02SECForm 144 filed
Aug 25INSInsider sell: Director
Aug 14SEC10-Q filed
Aug 10INSInsider sell: EVP, Operations
Aug 04INSInsider sell: General Counsel

Sign up to see the real RIGL record →

Company facts

SEC EDGAR registration

Name: RIGEL PHARMACEUTICALS INC
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -50sample, -100 to +100
Reporting currency: USD

Who is positioning in RIGL

sample

Insiders: 30 insider transactions over 90 days, net selling, $466.9M
Congress: 2 members traded over 90 days
Institutions · 13F: 7 funds hold $1.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$4.0B +25.4% y/y

Q4 2024Q3 2026

Inventory$2.3B +12.7% y/y

Q4 2024Q3 2026

Accounts receivable$1.7B +12.7% y/y

Q4 2024Q3 2026

Total debt$4.4B +3.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $50.6B -0.8% 3M
Sample peer B: $79.3B +7.0% 3M
Sample peer C: $50.3B +8.5% 3M
Sample peer D: $86.9B -3.9% 3M
Sample peer E: $100.1B +9.9% 3M